Results 201 to 210 of about 50,006 (352)

A case report of male breast cancer treated with breast-conserving surgery. [PDF]

Int J Surg Case Rep
Yoneyama K, Nakagawa M, Hara A.
europepmc   +1 more source

Opioids in breast cancer: Between analgesia and modulation of tumour progression

British Journal of Pharmacology, EarlyView.
Preclinical investigations consistently demonstrate that activation of μ‐opioid receptors and δ‐opioid receptors promote proliferation, migration, angiogenesis, epithelial‐mesenchymal transition, acquisition of cancer stem cell phenotypes, and chemoresistance.
Marianna Ciwun, Anna Tankiewicz‐Kwedlo, Dariusz Pawlak   +2 more
wiley   +1 more source

Combination of Hatchet and Anterior Intercostal Artery Perforator Flaps in Oncoplastic Breast-conserving Surgery. [PDF]

Plast Reconstr Surg Glob Open
Katsuragi R, Zaha H, Koki A, Okiyama M, Abe N.   +4 more
europepmc   +1 more source

Automated Tumor Segmentation in Breast-Conserving Surgery Using Deep Learning on Breast Tomosynthesis

Wen-Pei Wu, Yu-Wen Chen, Hwa‐Koon Wu, Dar‐Ren Chen, Yu-Len Huang   +4 more
openalex   +2 more sources

Matsupexole: A novel nonergot dopamine receptor agonist with sustained efficacy in a rat model of Parkinson's disease and limited off‐target activity

British Journal of Pharmacology, EarlyView.
Background and Purpose Dopamine receptor agonists, particularly targeting the dopamine D2L receptor (D2LR), have been used to treat Parkinson's disease (PD). However, valvular heart disease and somnolence, mainly caused by activating the serotonin 5‐HT2B receptor (5‐HT2BR) and dopamine D3 receptor (D3R), respectively, currently challenge their clinical
Takayuki Suzuki, Fumiki Oana, Masaki Oota, Yuma Handa, Osamu Kaminuma   +4 more
wiley   +1 more source

A preoperative predictive model for margin status in breast-conserving surgery. [PDF]

Breast
Liu X, Liu Y, Zhang S, Ma T, Liu L, Zhang J.   +5 more
europepmc   +1 more source

Lipofilling after breast conserving surgery: a plastic surgery perspective [PDF]

Gland Surgery, 2020
Melisa D, Granoff, Lifei, Guo, Dhruv, Singhal   +2 more
openaire   +2 more sources

IRF4 Enhances Radiosensitivity of Cervical Cancer by Inhibiting the PI3K/Akt/mTOR Pathway to Regulate Autophagy

Cancer Science, EarlyView.
IRF4 is a prognostic biomarker in cervical cancer. IRF4 enhances radiosensitivity and inhibits tumor growth via PI3K/AKT/mTOR‐mediated autophagy. IRF4 boosts radiation response in vitro and in vivo. ABSTRACT Interferon regulatory factor 4 (IRF4), a critical member of the IRF transcription factor family, harbors an elusive biological role in cervical ...
Meihui Gao, Zhaolei Cui, Huachun Song, Yanhong Li, Anyang Li, Jianfeng Zheng, Linying Liu, Xuefen Lin, Wankai Fu, Yang Sun   +9 more
wiley   +1 more source

Trajectories and risk factors for long-term breast symptoms following breast-conserving surgery and radiotherapy: a single centre analysis. [PDF]

Support Care Cancer
Jones C, Nurmahomed N, Kaushik M, Krupa J, Lambert KV, Pilgrim SM, Kancherla K, Sampson K, Sasi W, Seibold P, Symonds RP, Valassiadou K, Webb AJ, West C, Talbot CJ, Rattay T.   +15 more
europepmc   +1 more source

Pembrolizumab for Early‐Stage Triple‐Negative Breast Cancer: KEYNOTE‐522 Japan Subgroup Analysis

Cancer Science, EarlyView.
In the global, phase 3 KEYNOTE‐522 study of high‐risk early‐stage triple‐negative breast cancer (TNBC), neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab improved efficacy outcomes versus neoadjuvant chemotherapy alone. In this analysis of Japanese participants from KEYNOTE‐522, neoadjuvant pembrolizumab plus chemotherapy ...
Masato Takahashi, Hirofumi Mukai, Toshimi Takano, Koichiro Tsugawa, Kenichi Inoue, Mitsuya Itoh, Junichiro Watanabe, Yuko Tanabe, Naohito Yamamoto, Yasuo Miyoshi, Kenichi Watanabe, Toru Mukohara, Yibin Kong, Masashi Shimura, Francisco Beca, Peter Schmid, Hiroji Iwata   +16 more
wiley   +1 more source